Cargando…
ZEB2, the Mowat-Wilson Syndrome Transcription Factor: Confirmations, Novel Functions, and Continuing Surprises
After its publication in 1999 as a DNA-binding and SMAD-binding transcription factor (TF) that co-determines cell fate in amphibian embryos, ZEB2 was from 2003 studied by embryologists mainly by documenting the consequences of conditional, cell-type specific Zeb2 knockout (cKO) in mice. In between,...
Autores principales: | Birkhoff, Judith C., Huylebroeck, Danny, Conidi, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304685/ https://www.ncbi.nlm.nih.gov/pubmed/34356053 http://dx.doi.org/10.3390/genes12071037 |
Ejemplares similares
-
Zeb2 DNA-Binding Sites in Neuroprogenitor Cells Reveal Autoregulation and Affirm Neurodevelopmental Defects, Including in Mowat-Wilson Syndrome
por: Birkhoff, Judith C., et al.
Publicado: (2023) -
Mowat-Wilson syndrome
por: Garavelli, Livia, et al.
Publicado: (2007) -
A novel nonsense mutation of ZEB2 gene in a Chinese patient with Mowat‐Wilson syndrome
por: Hu, Yuan, et al.
Publicado: (2020) -
Clinical characteristics of Polish patients with molecularly confirmed Mowat-Wilson syndrome
por: Jakubiak, Aleksandra, et al.
Publicado: (2021) -
Mowat-Wilson syndrome: growth charts
por: Ivanovski, Ivan, et al.
Publicado: (2020)